A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
NCT01843790
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
GCS-100
DRUG:
Placebo, Saline
Sponsor
La Jolla Pharmaceutical Company